Search

Search Results

• Efficacy and Safety of Various Treatment Regimens for Primary CNS Lymphoma: Results of a Retrospective Study Based on the Data from Nine Saint Petersburg Medical Institutions

  Vladislav Vitalevich Markelov, Iu.S. Osipov, Yu.A. Alekseeva, S.V. Voloshin, N.A. Khasanova, S.A. Volchenkov, E.A. Ukrainchenko, E.S. Pavlyuchenko, A.Yu. Kuvshinov, Ju.N. Vinogradova, A.N. Gavrilenko, O.S. Uspenskaya, M.A. Ulyanova, V.G. Potapenko, I.A. Samorodova, V.V. Ryabchikova, I.S. Zyuzgin, A.M. Chekalov, M.V. Krivitskaya, Ya.B. Skiba, M.O. Popova, E.V. Kondakova, L.V. Stelmakh, L.V. Fedorova, K.V. Lepik, A.A. Gusak, V.V. Baykov, N.V. Medvedeva, G.N. Salogub, N.B. Mikhailova, A.D. Kulagin

  253-263

  01.07.2026

• The Optimal Background Cut-Off Threshold for Calculating Volumetric PET Biomarkers as Prognostic Factors in Classical Hodgkin Lymphoma

  Mariya Vasilevna Metelkina, I.P. Aslanidi, O.V. Mukhortova, D.M. Pursanova, V.A. Manukova, I.V. Shurupova, T.A. Trifonova, D.D. Zubkov, A.S. Rumyantsev

  39-48

  01.01.2026

• Effectiveness of the Initial Escalation of Immunochemotherapy in Patients with High Risk MALT-Lymphoma: Pilot Study Results

  Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, S.A. Tatarnikova, A.V. Belyaeva, A.M. Kovrigina, E.G. Gemdzhyan, E.E. Zvonkov

  338-348

  01.07.2025

• The Prognostic Value of ТР53 Gene Mutations in Patients with Cutaneous T-Cell Lymphomas

  Liliya Gamilevna Gorenkova, B.V. Biderman, A.K. Smolianinova, E.E. Zvonkov

  227-232

  01.07.2025

• Response-Adapted Strategy in the Treatment of Primary Mediastinal Large B-Cell Lymphoma: Results of a Prospective Single-Center Clinical Trial

  Yana Konstantinovna Mangasarova, R.R. Abdurashidova, A.U. Magomedova, O.V. Margolin, E.S. Nesterova, L.G. Gorenkova, M.O. Bagova, E.A. Fastova, D.S. Belkina, A.M. Kovrigina, N.G. Gabeeva, D.A. Koroleva, S.K. Kravchenko, Yu.A. Chabaeva, E.E. Zvonkov

  335-346

  01.10.2024

• Impact of Cardiac Disease on Prognosis in Patients with Systemic AL Amyloidosis

  Olga Vladislavovna Pirogova, O.V. Kudyasheva, M.V. Chernous, M.A. Gorodnova, D.K. Lamden, K.A. Novitskaya, A.G. Smirnova, A.V. Yakovleva, V.A. Ionin, A.M. Ananin, I.S. Moiseev, A.D. Kulagin

  237-245

  01.07.2024

• Treatment of Patients with Local Stages of Newly Diagnosed Classical Hodgkin Lymphoma: A Literature Review, Current Approaches, and Our Own Experience

  Evgeniya Viktorovna Paramonova, Yu.I. Klyuchagina, M.Yu. Kichigina, D.N. Tupitsyna, V.O. Shpirko, A.V. Arakelyan, A.A. Semenova, E.A. Demina, O.P. Trofimova, A.S. Subbotin, M.A. Senchenko, G.S. Tumyan

  27-36

  17.05.2024

• Ibrutinib in Chronic Lymphocytic Leukemia Therapy for High- and Very-High-Risk Patients over 60 Years of Age

  Nadezhda Viktorovna Kurkina, E.A. Repina, E.I. Gorshenina, V.O. Kurkina, P.V. Volkova, A.A. Repin

  37-42

  17.05.2024

• Follicular Lymphoma of Grades 1–3А With and Without t(14;18)(q32;q21): A Prognosis, Choice of Chemotherapy and Its Outcomes

  Ekaterina Sergeevna Nesterova, E.E. Zvonkov, A.M. Kovrigina, T.N. Obukhova, B.V. Biderman, A.B. Sudarikov, Ya.K. Mangasarova, A.U. Magomedova, A.K. Smolyaninova, S.M. Kulikov, E.N. Parovichnikova

  361-369

  28.09.2023

• Mutation Profile of Normal and Tumor Cells in a Patient with Multiple Myeloma: A Case Report

  A.S. Zhuk, I.I. Kostroma, Elena Igorevna Stepchenkova, D.V. Kachkin, O.B. Belopolskaya, I.V. Zotova, A.D. Garifullin, S.V. Voloshin, S.V. Gritsaev, A.Yu. Aksenova

  337-349

  09.06.2023

• KIR-Genetic Factors and Response to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia

  Elena Vital’evna Kuzmich, I.E. Pavlova, L.N. Bubnova, S.S. Bessmeltsev

  119-127

  03.03.2023

• The Prognostic Role of Genetic Aberrations in Mantle Cell Lymphoma: A Literature Review and Clinical Experience

  Elizaveta Vyacheslavovna Kleina, S.V. Voloshin, Yu.S. Vokueva, O.D. Petukhova, E.V. Motyko, M.P. Bakai, D.V. Kustova, A.N. Kirienko, S.Yu. Linnikov, E.V. Karyagina, O.S. Uspenskaya, I.S. Zyuzgin, S.V. Sidorkevich, I.S. Martynkevich

  213-226

  03.03.2023

• Identification of Somatic Mutations in EZH2 Gene and Assessment of Their Prognostic Value in Follicular Lymphoma Grades 1–3А

  Ekaterina Sergeevna Nesterova, N.A. Severina, B.V. Biderman, A.B. Sudarikov, A.M. Kovrigina, T.N. Obukhova, Ya.K. Mangasarova, S.M. Kulikov, E.E. Zvonkov, E.N. Parovichnikova, V.G. Savchenko

  80-87

  01.01.2023

• Efficacy Predictors of the Third-Line Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase of Chronic Myeloid Leukemia: Results of a Multi-Center Study

  E.G. Lomaia, V.A. Shuvaev, Tamara Vangelevna Chitanava, Yu.D. Matvienko, I.S. Martynkevich, S.V. Voloshin, E.V. Efremova, E.S. Mileeva, M.S. Fominykh, A.E. Kersilova, E.V. Karyagina, N.V. Il’ina, N.V. Dorofeeva, N.V. Medvedeva, A.V. Klimovich, T.V. Shneider, S.A. Stepanova, N.F. Polezhaikovskaya, N.T. Siordiya, E.I. Sbityakova, N.S. Lazorko, E.N. Tochenaya, D.V. Motorin, N.A. Shnalieva, Yu.A. Alekseeva, D.B. Zammoeva, A.Yu. Zaritskey

  271-281

  01.07.2022

• Prediction of Treatment Efficacy in Relapsed Chronic Lymphocytic Leukemia

  Olga Borisovna Kalashnikova, I.S. Moiseev, T.L. Gindina, E.A. Izmailova, M.O. Ivanova, E.V. Kondakova, N.B. Mikhailova, A.D. Kulagin

  466-476

  01.10.2021

• Current View on Diagnosis and Treatment of Classical Ph-Negative Myeloproliferative Neoplasms

  Anait Levonovna Melikyan, I.N. Subortseva, V.A. Shuvaev, E.G. Lomaia, E.V. Morozova, L.A. Kuzmina, O.Yu. Vinogradova

  129-137

  01.01.2021

• Long-Term Outcomes of Nivolumab Therapy in Patients with Relapsed/Refractory Classic Hodgkin’s Lymphoma after High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Real Clinical Practice

  Kirill Viktorovich Lepik, N.P. Volkov, N.B. Mikhailova, E.V. Kondakova, L.A. Tsvetkova, Yu.R. Zalyalov, E.E. Lepik, L.V. Fedorova, A.V. Beinarovich, M.V. Demchenkova, O.G. Smykova, P.V. Kotselyabina, I.S. Moiseev, V.V. Baikov, B.V. Afanasyev

  280-288

  01.07.2020

• Hodgkin’s Lymphoma: Analysis Results of Volgograd Regional Registry

  Kamil Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian

  363-376

  01.10.2019

• Severe Hypofunction of Allogeneic Hematopoietic Stem Cell Transplant in Patients with Oncohematological Diseases: Incidence, Risk Factors, and Outcomes

  Tat’yana Aleksandrovna Rudakova, A.D. Kulagin, O.U. Klimova, I.K. Golubovskaya, E.I. Darskaya, T.A. Bykova, A.G. Smirnova, E.V. Morozova, S.N. Bondarenko, I.S. Moiseev, A.V. Beinarovich, D.E. Pevtsov, A.L. Alyanskii, E.V. Babenko, I.M. Barkhatov, B.V. Afanas’ev

  309-318

  01.07.2019

• Primary Bone Lymphomas: Long-Term Results of a Prospective Single-Center Trial

  Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, V.E. Mamonov, S.A. Tatarnikova, L.G. Gorenkova, D.S. Badmadzhapova, A.M. Kovrigina, E.G. Gemdzhian, E.E. Zvonkov

  247-262

  01.07.2019

• Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues

  Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian, D.S. Abramov, D.M. Konovalov, G.L. Snigur, N.A. Red’kina

  154-164

  01.04.2019

• Clinical and Hematological Predictors of Response to First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma

  Svetlana Valer’evna Samarina, E.L. Nazarova, N.V. Minaeva, E.N. Zotina, I.V. Paramonov, S.V. Gritsaev

  68-72

  01.01.2019

• Evolution of Anti-Cancer Treatment and its Impact on Surrogate Prognostic Factors in Multiple Myeloma

  Aleksandr Sergeevich Luchinin, S.V. Semochkin, N.V. Minaeva, N.M. Pozdeev, I.V. Paramonov

  175-181

  01.04.2018

• Hematopoietic Stem Cell Collection in Multiple Myeloma Patients: Influence of the Lenalidomide-Based Therapy and Mobilization Regimen Prior to Auto-HSCT

  Ivan Ivanovich Kostroma, A.A. Zhernyakova, Zh.V. Chubukina, I.M. Zapreeva, S.A. Tiranova, A.V. Sel’tser, N.Yu. Semenova, S.S. Bessmel’tsev, A.V. Chechetkin, S.V. Gritsaev

  192-197

  01.04.2018

• Role of Positron-Emission Tomography in Prognosis of Outcomes of High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Hodgkin’s Lymphoma

  Vsevolod Gennad’evich Potapenko, N.B. Mikhailova, B.I. Smirnov, I.A. Skorokhod, D.A. Chaginskaya, V.V. Ryabchikova, I.A. Samorodova, E.I. Podol’tseva, V.V. Ipatov, I.V. Boikov, V.N. Semelev, D.A. Gornostaev, T.G. Potapenko, T.G. Kulibaba, N.V. Medvedeva, B.V. Afanas’ev

  406-412

  01.10.2016

• Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemias with Hyperdiploid Karyotype

  Tat’yana Leonidovna Gindina, N.N. Mamaev, E.S. Nikolaeva, S.N. Bondarenko, O.A. Slesarchuk, A.S. Borovkova, S.V. Razumova, O.V. Pirogova, A.L. Alyanskii, L.S. Zubarovskaya, B.V. Afanas’ev

  383-390

  01.10.2016

• Genetic Mutations in Acute Myeloid Leukemia

  Ol’ga Vladimirovna Blau

  245-256

  01.07.2016

• Epstein-Barr Virus and Classical Hodgkin’s Lymphoma

  Vladimir Eduardovich Gurtsevich

  101-114

  01.04.2016

• Primary Incidence of Hematological Malignancies in Saint Petersburg in 1990–2011 and Prognosis till 2021

  Lyubov’ Yur’evna Zhiguleva, K.M. Abdulkadyrov

  362-367

  01.10.2015

• Bone Marrow Transplantation in Patients with Acute Lymphoblastic Leukemia with Extremely Poor Prognosis: Literature Review and Case Report

  Natal’ya Nikolaevna Subbotina, A.V. Popa, I.S. Dolgopolov, V.K. Boyarshinov, R.I. Pimenov, V.V. Dailidite, G.L. Mentkevich

  331-336

  01.07.2015

• Multiple myeloma (management of newly diagnosed patients): literature review and our on data. Part II

  S.S. Bessmeltsev

  379-414

  01.10.2013

• International prognostic score in advanced Hodgkin’s lymphoma

  K.D. Kaplanov, A.L. Shipaeva, V.A. Vasil’yeva, E.G. Gemdjian, I.V. Matveeva, L.S. Tregubova, T.U. Klitochenko, K.V. Demidenko, O.B. Kalashnikova, G.U. Vyskub, O.E. Golubeva, O.V. Levina, V.A. Orlov, E.A. Demina

  294-302

  01.07.2013